Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.900 | 0.953 | 190 | 2006 | 2020 | ||||||
Diabetes Mellitus
|
824 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.100 | 1.000 | 37 | 2006 | 2020 | ||||||
Diabetes
|
710 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.100 | 1.000 | 35 | 2006 | 2020 | ||||||
Hyperglycemia
|
108 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.070 | 1.000 | 7 | 2006 | 2020 | ||||||
Peripheral Arterial Diseases
|
128 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.710 | 1.000 | 2 | 2019 | 2020 | ||||||
Peripheral Vascular Diseases
|
18 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2020 | 2020 | ||||||
Gestational Diabetes
|
224 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.100 | 0.944 | 18 | 2007 | 2019 | ||||||
Obesity
|
1111 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.100 | 0.900 | 10 | 2008 | 2019 | ||||||
Body mass index
|
2689 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.800 | 1.000 | 9 | 2012 | 2019 | ||||||
Fasting blood glucose measurement
|
212 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.800 | 1.000 | 5 | 2009 | 2019 | ||||||
Latent autoimmune diabetes mellitus in adult
|
12 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.050 | 1.000 | 5 | 2008 | 2019 | ||||||
Diabetes Mellitus, Insulin-Dependent
|
954 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.040 | 0.750 | 4 | 2007 | 2019 | ||||||
Latent Autoimmune Diabetes in Adults
|
12 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.020 | 1.000 | 2 | 2019 | 2019 | ||||||
Adenocarcinoma of the gastroesophageal junction
|
6 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Birth Weight
|
369 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||
Glycosuria
|
7 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||
Ischemic stroke
|
704 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Large-artery atherosclerosis (embolus/thrombosis)
|
35 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Systolic Pressure
|
1931 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||
Metabolic Syndrome X
|
591 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.870 | 0.875 | 8 | 2008 | 2018 | ||||||
Breast Carcinoma
|
2793 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.060 | 1.000 | 6 | 2012 | 2018 | ||||||
Malignant neoplasm of breast
|
3417 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.060 | 1.000 | 6 | 2012 | 2018 | ||||||
Colorectal Carcinoma
|
1962 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.030 | 1.000 | 3 | 2008 | 2018 | ||||||
Diabetic Nephropathy
|
238 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.030 | 1.000 | 3 | 2014 | 2018 | ||||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.020 | 1.000 | 2 | 2008 | 2018 |